
GC60626
BCL6-IN-5
Also known as 5-[(2,5-dichloropyrimidin-4-yl)amino]-3-(3-hydroxy-3-methylbutyl)-1-methylbenzimidazol-2-one
BCL6-IN-5 is a potent BCL6 inhibitor exacted from patent WO2018215801A1, example 1n, has a pIC50 of 5·82
ChemicalCAS2253878-09-8MW396.27FormulaC17H19Cl2N5O2
- CAS number
- 2253878-09-8
- Molecular weight
- 396.27
- Formula
- C17H19Cl2N5O2
- Solubility
- DMSO: 20·83 mg/mL (52·57 mM)
- InChIKey
- NKMQWLPBEJJYCN-UHFFFAOYSA-N
- Catalogue number
- GC60626
- Brand
- GLPBIO
Computed properties PubChem CID 135386935 · XLogP 3 · TPSA 81.6 Ų · H-bond donors 2
- XLogP
- 3
- TPSA
- 81.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES CC(C)(CCN1C2=C(C=CC(=C2)NC3=NC(=NC=C3Cl)Cl)N(C1=O)C)O
Computed descriptors from PubChem (CID 135386935), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il